Viridian Therapeutics, Inc. (VRDN)

Healthcare · Biotechnology · NASDAQ

Viridian Therapeutics, Inc. (VRDN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.51B and a free-cash-flow yield of -14.8%. Over the most recent reported fiscal year, revenue grew 23359.9%.

Market cap	$2.51B
Trailing P/E	—
FCF yield	-14.8%
Revenue growth (YoY)	+23359.9%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live VRDN data on Nama Insights →